HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
100.99
-3.14 (-3.02%)
Jul 30, 2026, 4:00 PM EDT - Market closed
HealthEquity Ratios and Metrics
Market cap in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
| 8,443 | 7,283 | 9,555 | 6,509 | 5,158 | 4,477 | |
Market Cap Growth | 1.96% | -23.79% | 46.79% | 26.21% | 15.20% | -30.56% |
Enterprise Value | 9,162 | 7,965 | 10,368 | 7,039 | 5,898 | 5,260 |
Last Close Price | 100.99 | 85.67 | 110.42 | 75.58 | 60.85 | 53.44 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
PE Ratio | 37.88 | 34.83 | 101.30 | 118.09 | - | - |
Forward PE | 20.70 | 19.75 | 31.70 | 28.55 | 36.76 | 40.27 |
PEG Ratio | 1.36 | 1.16 | 1.28 | 1.17 | 1.33 | 3.58 |
PS Ratio | 6.31 | 5.54 | 7.96 | 6.51 | 5.98 | 5.92 |
PB Ratio | 4.14 | 3.46 | 4.52 | 3.20 | 2.72 | 2.42 |
P/FCF Ratio | 17.31 | 16.00 | 28.29 | 27.00 | 35.02 | 33.90 |
P/OCF Ratio | 17.23 | 15.93 | 28.12 | 26.81 | 34.24 | 31.75 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
EV/Sales Ratio | 6.85 | 6.06 | 8.64 | 7.04 | 6.84 | 6.95 |
EV/EBITDA Ratio | 18.46 | 16.69 | 31.92 | 25.99 | 34.64 | 46.57 |
EV/EBIT Ratio | 26.76 | 24.70 | 63.87 | 59.80 | 651.18 | - |
EV/FCF Ratio | 18.79 | 17.50 | 30.69 | 29.19 | 40.04 | 39.82 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Debt / Equity Ratio | 0.48 | 0.47 | 0.52 | 0.45 | 0.51 | 0.53 |
Debt / EBITDA Ratio | 1.98 | 2.10 | 3.41 | 3.45 | 5.84 | 8.93 |
Debt / FCF Ratio | 2.02 | 2.20 | 3.28 | 3.87 | 6.75 | 7.63 |
Net Debt / Equity Ratio | 0.35 | 0.32 | 0.38 | 0.26 | 0.39 | 0.42 |
Net Debt / EBITDA Ratio | 1.45 | 1.43 | 2.50 | 1.95 | 4.35 | 6.93 |
Net Debt / FCF Ratio | 1.48 | 1.50 | 2.41 | 2.19 | 5.03 | 5.93 |
Asset Turnover | 0.40 | 0.38 | 0.36 | 0.32 | 0.28 | 0.26 |
Quick Ratio | 2.85 | 2.82 | 2.65 | 4.35 | 2.68 | 2.04 |
Current Ratio | 3.44 | 3.27 | 3.06 | 4.76 | 2.92 | 2.29 |
Return on Equity (ROE) | 5.34% | 10.19% | 4.66% | 2.83% | -1.39% | -2.74% |
Return on Assets (ROA) | 7.88% | 7.33% | 4.09% | 2.80% | 0.20% | -0.55% |
Return on Invested Capital (ROIC) | 9.51% | 8.75% | 4.93% | 3.36% | 0.24% | -0.68% |
Return on Capital Employed (ROCE) | 10.62% | 9.90% | 5.12% | 3.92% | 0.31% | -0.89% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Earnings Yield | 2.73% | 2.87% | 0.99% | 0.85% | - | - |
FCF Yield | 5.78% | 6.25% | 3.53% | 3.70% | 2.86% | 2.95% |
Buyback Yield / Dilution | 2.51% | 1.53% | -2.15% | -2.98% | -1.57% | -9.85% |
Total Shareholder Return | 2.51% | 1.53% | -2.15% | -2.98% | -1.57% | -9.85% |